Jeffrey L. Tate
Net Worth

Last updated:

What is Jeffrey L. Tate net worth?

The estimated net worth of Dr. Jeffrey L. Tate is at least $1,299,433 as of 20 Oct 2023. He owns shares worth $23,733 as insider and has received compensation worth at least $1,275,700 in Cyclo Therapeutics, Inc..

What is the salary of Jeffrey L. Tate?

Dr. Jeffrey L. Tate salary is $255,140 per year as Chief Operating Officer, Chief Quality Officer & Director in Cyclo Therapeutics, Inc..

How old is Jeffrey L. Tate?

Dr. Jeffrey L. Tate is 67 years old, born in 1958.

What stocks does Jeffrey L. Tate currently own?

As insider, Dr. Jeffrey L. Tate owns shares in one company:

Company Title Shares Price per share Total value
Cyclo Therapeutics, Inc. (CYTH) Chief Operating Officer, Chief Quality Officer & Director 32,935 $0.72 $23,733

What does Cyclo Therapeutics, Inc. do?

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

CYTH logo
CYTH
Cyclo Therapeutics, Inc.
$0.72

Jeffrey L. Tate insider trading

Cyclo Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Warrant to Purchase Common Stock 32,935 $0.95 $31,288
Purchase
Warrant to Purchase Common Stock 29,941 $0.71 $21,258
Purchase
Common Stock 29,941 $0.71 $21,258
Purchase
Common Stock 3,000 $2.12 $6,354
Purchase
Common Stock 1,065 $2.71 $2,882
Purchase
Common Stock 300 $2.7 $810
Purchase
Common Stock 635 $2.5 $1,588
Purchase
Common Stock 2,000 $7.5 $15,000
Purchase
Warrant to Purchase Common Stock 5,000 $5 $25,000

Cyclo Therapeutics key executives

Cyclo Therapeutics, Inc. executives and other stock owners filed with the SEC: